EP3973987
COMBINATION COMPRISING AN IL-4R ANTAGONIST, A CORTICOSTEROID AND A LONG-ACTING BETA2-ADRENERGIC AGONIST FOR TREATING ASTHMA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
20.2.2015EP published:
10.1.2024EP application number:
21191120.1
EPO information:
European Patent Register
Max expiry date:
19.2.2035
Title in English:
COMBINATION COMPRISING AN IL-4R ANTAGONIST, A CORTICOSTEROID AND A LONG-ACTING BETA2-ADRENERGIC AGONIST FOR TREATING ASTHMALanguage of the patent:
English
Timeline
Today
20.2.2015EP application
10.1.2024EP Publication
Owner
Name:
Sanofi BiotechnologyAddress:
82 Avenue Raspail, 94250 Gentilly, FR
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, US
Inventor
Name:
PIROZZI, GianlucaAddress:
Bridgewater, 08807, US
Name:
SKOBIERANDA, FranckAddress:
Flourtown, 19031, US
Name:
LI, YongtaoAddress:
Bridgewater, 08807, US
Name:
GRAHAM, NeilAddress:
Tarrytown, 10591-6707, US
Name:
WEINSTEIN, Steven P.Address:
Tarrytown, 10591-6707, US
Priority
Number:
201461943019 PDate:
21.2.2014Country:
US
Number:
14306413Date:
15.9.2014Country:
EP
Number:
201462077669 PDate:
10.11.2014Country:
US
Classification
Categories:
A61K 39/395, A61K 31/00, A61K 31/167, A61K 31/56, A61P 11/06